Bluebird bio Inc
Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
0.953
-0.0103
(-1.069%)
Volume:
0
52 week range:
0.879 - 5.53
Market Cap:
104.197M
Company Description:
we are leading the gene therapy revolution. our integrated product platforms encompass gene therapy, cancer immunotherapy and gene editing – providing us with the potential to treat, and hopefully cure, a broad range of serious diseases. we have a lot of energy, and it’s not just the abundance of coffee that keeps us going. find out what sparks our excitement and inspires us every day.